CoChat

Delayed Inhibition of VEGF Signaling after Stroke Attenuates Blood–Brain Barrier Breakdown and Improves Functional Recovery in a Comorbidity-Dependent Manner

Open access
Reeson, Patrick, Tennant, Kelly A., Gerrow, Kim, Wang, Josh, Weiser Novak, Sammy, Thompson, Kelsey, Lockhart, Krista-Linn, Holmes, Andrew, Nahirney, Patrick C., Brown, Craig E. · 2015 · The Journal of Neuroscience
Cited by 139

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Diabetes is a common comorbidity in stroke patients and a strong predictor of poor functional outcome. To provide a more mechanistic understanding of this clinically relevant problem, we focused on how diabetes affects blood–brain barrier (BBB) function after stroke. Because the BBB can be compromised for days after stroke and thus further exacerbate ischemic injury, manipulating its function presents a unique opportunity for enhancing stroke recovery long after the window for thrombolytics has passed. Using a mouse model of Type 1 diabetes, we discovered that ischemic stroke leads to an abnormal and persistent increase in vascular endothelial growth factor receptor 2 (VEGF-R2) expression in peri-infarct vascular networks. Correlating with this, BBB permeability was markedly increased in diabetic mice, which could not be prevented with insulin treatment after stroke. Imaging of capillary ultrastructure revealed that BBB permeability was associated with an increase in endothelial transcytosis rather than a loss of tight junctions. Pharmacological inhibition (initiated 2.5 d after stroke) or vascular-specific knockdown of VEGF-R2 after stroke attenuated BBB permeability, loss of synaptic structure in peri-infarct regions, and improved recovery of forepaw function. However, the beneficial effects of VEGF-R2 inhibition on stroke recovery were restricted to diabetic mice and appeared to worsen BBB permeability in nondiabetic mice. Collectively, these results suggest that aberrant VEGF signaling and BBB dysfunction after stroke plays a crucial role in limiting functional recovery in an experimental model of diabetes. Furthermore, our data highlight the need to develop more personalized stroke treatments for a heterogeneous clinical population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.2810-14.2015

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 79

  1. 10.1007/s11940-011-0143-8 · DOI
  2. 10.1016/j.nbd.2003.12.016 · DOI · Paper page
  3. 10.1046/j.1471-4159.1994.62062404.x · DOI · Paper page
  4. 10.1161/01.STR.17.5.865 · DOI · Paper page
  5. 10.1161/STROKEAHA.109.551341 · DOI · Paper page
  6. 10.1371/journal.pone.0065663 · DOI
  7. 10.1097/01.WCB.0000078322.96027.78 · DOI · Paper page
  8. 10.1161/01.STR.24.1.111 · DOI · Paper page
  9. 10.1038/jcbfm.2014.18 · DOI · Paper page
  10. 10.1016/j.ejca.2006.09.015 · DOI · Paper page
  11. 10.1016/j.jneumeth.2005.10.011 · DOI
  12. Feng, 1999, VEGF-induced permeability increase is mediated by caveolae, Invest Ophthalmol Vis Sci, 40, 157
  13. 10.1523/JNEUROSCI.5977-11.2012 · DOI · Paper page
  14. 10.1006/mvre.2001.2367 · DOI · Paper page
  15. Fong, 1999, SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types, Cancer Res, 59, 99
  16. 10.1002/gene.10117 · DOI · Paper page
  17. 10.1182/blood-2002-10-3023 · DOI · Paper page
  18. 10.1161/01.cir.0000441139.02102.80 · DOI · Paper page
  19. Gu, 2001, Vascular endothelial growth factor-A and -C protein up-regulation and early angiogenesis in a rat photothrombotic ring stroke model with spontaneous reperfusion, Acta Neuropathol, 102, 216, 10.1007/s004010100370 · DOI
  20. 10.1016/1056-8727(95)80013-5 · doi:10.1016/1056-8727(95)80013-5
  21. 10.2337/diab.46.5.847 · DOI · Paper page
  22. 10.1007/s00125-006-0485-z · DOI · Paper page
  23. 10.1016/j.freeradbiomed.2005.03.035 · DOI · Paper page
  24. 10.1016/j.stem.2009.01.006 · DOI · Paper page
  25. 10.1161/ATVBAHA.114.303090 · DOI · Paper page
  26. 10.1007/s100720200018 · DOI
  27. 10.1523/JNEUROSCI.4318-13.2013 · DOI · Paper page
  28. 10.1038/sj.bjc.6603813 · DOI · Paper page
  29. 10.1172/JCI111764 · DOI · Paper page
  30. 10.1371/journal.pone.0056419 · DOI · Paper page
  31. 10.1016/j.jns.2008.02.020 · DOI
  32. 10.1038/sj.jcbfm.9600382 · DOI
  33. 10.1007/BF00688633 · DOI · Paper page
  34. 10.1016/j.cell.2007.06.054 · DOI · Paper page
  35. 10.2337/db09-0902 · DOI · Paper page
  36. 10.1016/j.brainres.2013.10.021 · DOI
  37. Lossinsky, 2004, Structural pathways for macromolecular and cellular transport across the blood–brain barrier during inflammatory conditions, Histol Histopathol, 19, 535
  38. 10.1038/jcbfm.2010.210 · DOI
  39. Manoonkitiwongsa P Schultz R Lyden P (2011) in Therapeutic angiogenesis for vascular diseases, Safe and effective vascular endothelial cell growth factor (VEGF)-based therapeutic angiogenesis for ischemic stroke: insights from preclinical trials, ed Slevin M (Springer, Amsterdam), pp 169–212. · DOI
  40. Mendel, 2000, The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function, Clin Cancer Res, 6, 4848
  41. 10.1371/journal.pone.0044547 · DOI · Paper page
  42. Minchenko, 1994, Hypoxia regulatory elements of the human vascular endothelial growth-factor gene, Cell Mol Biol Res, 40, 35
  43. 10.1002/dvdy.20982 · DOI · Paper page
  44. 10.1523/JNEUROSCI.3908-10.2010 · DOI · Paper page
  45. 10.1111/ijs.12225 · DOI
  46. 10.1097/00005344-199701000-00002 · DOI · Paper page
  47. 10.1097/00005344-199503000-00008 · DOI · Paper page
  48. 10.2337/db11-1528 · DOI
  49. 10.1161/STROKEAHA.113.001660 · DOI
  50. 10.1096/fj.01-0253hyp · DOI · Paper page
  51. 10.1016/j.nbd.2008.08.005 · DOI · Paper page
  52. 10.1038/nmeth.2019 · DOI · Paper page
  53. 10.1212/WNL.49.1.113 · DOI · Paper page
  54. 10.1016/j.brainres.2004.11.054 · DOI · Paper page
  55. 10.3389/fnene.2014.00001 · DOI
  56. 10.1016/j.neuroscience.2006.01.016 · DOI
  57. 10.1161/STROKEAHA.109.564229 · DOI
  58. 10.1523/JNEUROSCI.1779-09.2009 · DOI · Paper page
  59. 10.1182/blood-2008-08-174508 · DOI · Paper page
  60. 10.1007/s00125-002-0782-0 · DOI
  61. 10.1038/sj.jcbfm.9600320 · DOI · Paper page
  62. 10.1523/JNEUROSCI.5075-11.2012 · DOI
  63. 10.1523/JNEUROSCI.3513-13.2013 · DOI
  64. 10.1016/j.jneumeth.2009.04.009 · DOI · Paper page
  65. 10.1016/0006-291X(92)90483-2 · DOI · Paper page
  66. 10.1007/s001250051439 · DOI · Paper page
  67. 10.1007/BF00812155 · DOI
  68. 10.1016/j.jneumeth.2004.04.029 · DOI · Paper page
  69. 10.1007/BF01181571 · DOI
  70. 10.1016/S1056-8727(01)00212-4 · DOI
  71. 10.1126/scisignal.2004235 · DOI · Paper page
  72. 10.1161/STROKEAHA.110.586909 · DOI
  73. 10.1038/jcbfm.2010.119 · DOI · Paper page
  74. 10.1007/BF00691332 · DOI · Paper page
  75. 10.1002/ana.22538 · DOI · Paper page
  76. 10.1016/j.expneurol.2011.09.022 · DOI
  77. 10.1097/00004647-200204000-00002 · DOI · Paper page
  78. 10.1007/s12031-010-9487-x · DOI
  79. 10.1186/1472-6882-12-188 · DOI

Cited by

See all 139

Metadata

Authors
Reeson, P., Tennant, K. A., Gerrow, K., Wang, J., Weiser Novak, S., Thompson, K., Lockhart, K.-L., Holmes, A., Nahirney, P. C., & Brown, C. E.
Venue
The Journal of Neuroscience
Published
2015-04-01
Volume
35
Issue
13
Pages
5128-5143
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2083900005
Cited by
139
References
20
FWCI
8.60
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.